RBC Bearings delivered results ahead of Wall Street expectations in Q3, with the market responding positively to robust ...

Bearings manufacturer RBC Bearings (NYSE:RBC) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 14.4% year ...

RBC Capital analyst Matthew McKellar downgraded PotlatchDeltic (PCH) to Sector Perform from Outperform with an unchanged price target of $48. The ...

The production of red blood cells from stem cells has emerged as a transformative approach to address chronic blood shortages and meet the increasing demand for transfusion therapies. By harnessing ...

Q2 2026 Earnings Call Transcript October 31, 2025 RBC Bearings Incorporated beats earnings expectations. Reported EPS is ...

With a price-to-earnings multiple under 15x and its relative strength index below 40, Celanese Corporation (NYSE:CE) secures a spot on our list of the 13 Oversold Value Stocks to Invest in Now. RBC ...

Acanthocyte Erythrocyte identified by numerous spiny cytoplasmic projections; similar to a Burr cell Acanthocytosis, condition in which the majority of erythrocytes are acanthocytes. Anemia Deficiency ...

Detailed price information for RBC Bearings Inc (RBC-N) from The Globe and Mail including charting and trades.

ConocoPhillips raised its quarterly dividend and full-year production forecast on Thursday, but the third quarter results ...

Source: Getty Images Addressing anemia in CKD requires a proactive, multifaceted approach, incorporating both conventional and nutritional strategies. Early recognition and intervention are essential ...